peopleInnovationCareers RarePipelineCollaborationFinanceAdvance treatment Skip to main contentSkip to navigationSkip to search
HNSA   ( ,  %) SEK
Quotes are delayed 15 minutes
Lab vials pipette


The products mentioned are not currently available in all countries. Products are for hospital use only and can only be obtained with a prescription. Treatment should only be prescribed and supervised by a doctor experienced in the use of immunosuppressive medicines.


Idefirix® (imlifidase)

Idefirix® (imlifidase) specifically targets and cleaves all classes of immunoglobulin G (IgG) antibodies. Idefirix® is conditionally authorized by the European Commission (EC) for the desensitization treatment of highly sensitized adult kidney transplant patients with a positive crossmatch test against an available deceased donor. The use of imlifidase should be reserved for patients who are unlikely to be transplanted under the available kidney allocation system, including prioritization programs for highly sensitized patients.

Read the information on Idefirix® on the European Medicines Agency’s website